ClinVar Miner

Submissions for variant NM_000346.4(SOX9):c.479G>C (p.Arg160Pro)

dbSNP: rs1057518419
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000413454 SCV000492030 likely pathogenic not provided 2016-11-29 criteria provided, single submitter clinical testing The R160P variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. This variant has been observed apparently de novo at GeneDx. The R160P variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R160P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (A158T/V, H165Y/P/Q) have been reported in the Human Gene Mutation Database in association with campomelic dysplasia (Stenson et al., 2014), supporting the functional importance of this region of the protein.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.